Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-17

Clinical Trial Update: Penehyclidine for PONV Prophylaxis After Strabismus Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating penehyclidine for prophylaxis of postoperative nausea and vomiting after strabismus surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Penehyclidine (penehyclidine)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: PONV | Phase 4 | Status: COMPLETED